Safety and long-term efficacy of left subclavian artery coverage during thoracic endovascular aortic

来源 :2013中国心脏大会(CHC) | 被引量 : 0次 | 上传用户:hexiaole632
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background To observe the safety and long-term efficacy of left subclavian artery (LSA) coverage during thoracic endovascular aortic repair (TEVAR).
其他文献
Objective To study the efficacy of regularly clinic follow-up for outpatients with chronic heart failure (CHF) on proguosis and costbenefit Methods All patients diagnosed as CHF in our cardiovascular
会议
Background Acute myocardial infarction (AMI) due to unprotected left main coronary artery (ULMCA) occlusion has a poor prognosis.There is limited Result in patients undergoing primary percutaneous cor
会议
Background To investigate effects of intravenous vs intra-coronary injection of tirofiban on myocardial reperfusion during primly PCI in aptients with STEMI.
会议
Baekground The unprotected left main coronary artery (ULMCA)bifurcation stenosis remains challenging for percutaneous coronary intervention (PCI).The aim of the study was to evaluate the effectiveness
会议
Background Previous studies have reported that low final thrombolysis in myocardial infarction (TIMI) flow and/or myocardial blush grade (MBG) are independent predictors of mortality in patients with
会议
Background To observe the changes of the level of thyroid hormone in the patients with coronary atherosclerotic heart disease (CHD).Methods According to the Result of coronary artery angiography, 299
会议
Objective To perform an evaation (meta-analysis) on short-term and long-term prognosis of percutaneous coronary intervention (PCT) for patients with chronic total occlusions (CTO) recanalization.
会议
Objective Comparing the clinical characters of the early and median stage after the systemic-pulmonary shunts and the right ventricular to pulmonary artery connection (RV-PA connection)for pulmonary a
会议
Background Recently, several randomized trials which compared bivalirudin with heparin plus glycoprotein Ⅱb/Ⅲa inhibitors (GPIs)in patients undergoing percutaneous coronary intervention (PCI)had been
会议
Background To assess efficacy and safety of Fondaparinux during thrombolytic therapy in acute ST-elevation myocardial infarction patients.Methods From Nov.2011 to Apr.2012,patients with acute ST-eleva
会议